Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
106.15
-0.23 (-0.22%)
At close: Apr 24, 2025, 4:00 PM
102.52
-3.63 (-3.42%)
After-hours: Apr 24, 2025, 6:03 PM EDT
Gilead Sciences Stock Forecast
Stock Price Forecast
The 24 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 108.08, with a low estimate of 80 and a high estimate of 140. The average target predicts an increase of 1.82% from the current stock price of 106.15.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Gilead Sciences stock from 26 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 4 | 4 | 4 |
| Buy | 10 | 11 | 12 | 12 | 12 | 13 |
| Hold | 12 | 12 | 11 | 11 | 11 | 9 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 24 | 26 | 26 | 27 | 27 | 26 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $125 | Buy | Initiates | $125 | +17.76% | Apr 22, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $120 → $130 | Buy | Maintains | $120 → $130 | +22.47% | Mar 27, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $123 → $130 | Buy | Maintains | $123 → $130 | +22.47% | Mar 11, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $116 → $126 | Strong Buy | Maintains | $116 → $126 | +18.70% | Mar 5, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $120 → $140 | Buy | Maintains | $120 → $140 | +31.89% | Mar 5, 2025 |
Financial Forecast
Revenue This Year
29.30B
from 28.75B
Increased by 1.88%
Revenue Next Year
30.45B
from 29.30B
Increased by 3.95%
EPS This Year
8.11
from 0.38
Increased by 2,033.40%
EPS Next Year
8.57
from 8.11
Increased by 5.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 30.8B | 33.5B | 35.6B | ||
| Avg | 29.3B | 30.5B | 31.9B | ||
| Low | 27.8B | 28.4B | 28.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.3% | 14.3% | 16.9% | ||
| Avg | 1.9% | 3.9% | 4.6% | ||
| Low | -3.4% | -3.2% | -5.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 8.56 | 9.53 | 10.74 | ||
| Avg | 8.11 | 8.57 | 9.09 | ||
| Low | 7.60 | 6.34 | 6.89 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2,152.0% | 17.6% | 25.4% | ||
| Avg | 2,033.4% | 5.7% | 6.1% | ||
| Low | 1,898.7% | -21.8% | -19.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.